A Debate About Prescription Opioids

Are there people in acute pain who could benefit from prescription opioids? Yes.

Are there people who are addicted to and at risk of overdosing on prescription opioids? Yes.

That’s the nub of one of the most challenging problems in current drug policy: How do we regulate prescription opioids in a fashion that maximizes their positive medical impacts and minimizes their risks and harms?

Our most recent Stanford Health Policy Forum featured a civil, spirited debate about this question between Drs. Sean Mackey and Anna Lembke. In addition to being highly interesting, their discussion shows that (hooray!) at least some people can argue about drug policy while still respecting and listening to each other.

[The Reality-Based Community]

Support Nonprofit Journalism

If you enjoyed this article, consider making a donation to help us produce more like it. The Washington Monthly was founded in 1969 to tell the stories of how government really works—and how to make it work better. Fifty years later, the need for incisive analysis and new, progressive policy ideas is clearer than ever. As a nonprofit, we rely on support from readers like you.

Yes, I’ll make a donation

Keith Humphreys

Keith Humphreys is a professor of psychiatry at Stanford University. He served as a senior policy advisor at the White House Office of National Drug Control Policy from 2009 to 2010.